Fan-Cheng Kong

机构：MD Precision (Canada) · ORCID：0000-0002-1526-9112

发表论文 6 篇 · 总被引 43 次 · h-index 4

代表论文

Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application (2019 · Current Neuropharmacology · 被引 22)
Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients (2020 · Gene · 被引 10)
A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood–brain barrier (2022 · Bioengineered · 被引 5)
Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy (2025 · Drug Resistance Updates · 被引 2)
A novel epigenetic marker, TET2, is identified in the intractable epileptic brain and regulates ABCB1 in the blood-brain barrier (2021 · Research Square · 被引 2)
Homologous recombination deficiency (HRD) profiling in Chinese pancreatic ductal adenocarcinoma: Implications for platinum-based chemotherapy. (2025 · Journal of Clinical Oncology)